Citicoline: Clinical Trials

31 trials of Citicoline, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

16 completed, 4 recruiting, 3 unknown, 3 withdrawn. 10 Not applicable, 9 Phase 3, 7 Phase 2, 5 Phase 4, 1 Early Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable10Completed 6, Active not recruiting 1, Not yet recruiting 1, Recruiting 1, Withdrawn 1
Phase 39Completed 3, Recruiting 2, Terminated 2, Unknown 2
Phase 27Completed 2, Unknown 2, Active not recruiting 1, Recruiting 1, Withdrawn 1
Phase 45Completed 4, Withdrawn 1
Early Phase 11Completed 1
Phase 11Active not recruiting 1

Follow Citicoline: new trials by email Literature Review of Citicoline trials Research Report on Citicoline

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effect of Citicoline on Neurological Severity Score and Cerebral Doppler Resistive Index in Neonatal Hypoxic Ischemic Encephalopathy
Citicoline, Standard medical treatment - Hypoxic Ischaemic Encephalopathy (HIE)
Not applicableNot yet recruitingKhyber Girls Medical College862026-09-012026-08-24
CITADEL: Effectiveness of CITicoline in Preventing Cognitive Decline After DELirium
Citicoline - Cognitive Decline, Delirium
Phase 2RecruitingUniversity of Milano Bicocca1222026-06-032026-09-09
Evaluate the Effects of Citicoline on Mood in Healthy Adults
Citicoline, Placebo - Healthy
Not applicableRecruitingKirin Holdings Company, Limited902025-07-312025-09-02
Supplemental Citicoline Administration to Reduce Lung Injury Efficacy Trial (SCARLET)
Citicoline, Saline/Placebo - COVID-19
Phase 1 / Phase 2Active not recruitingOhio State University802023-06-062025-04-02
Multimodal Morpho-functional Study in Glaucoma Patients-Citicoline Oral Solution
Citicoline, Placebo - Primary Open Angle Glaucoma
Not applicableActive not recruitingFondazione G.B. Bietti, IRCCS292022-01-252025-02-26
Citicoline and Filtration Surgery
Citicoline, Placebo - Glaucoma Therapy
Not applicableCompletedFondazione IRCCS Policlinico San Matteo di Pavia62021-08-102026-05-05
The Impact of Air Travel on Passenger Cognitive Functions
Citicoline, Cytochrome C6, Sodium Chloride Oral Product - Air Travel
Phase 2 / Phase 3UnknownDinara Zhumanbayeva502021-06-012021-03-17
Citicoline as Neuroprotector in Preterm
Citicoline, Placebo oral tablet - Pre-Term
Phase 3RecruitingSherief Abd-Elsalam402019-05-012019-05-29
Citicoline as Neuroprotector in Neonates Exposed to Hypoxia
Citicoline, Placebo - Neonatal Hypoxia
Phase 3RecruitingSherief Abd-Elsalam402019-02-012019-05-29
Citicoline Concentration in Human Vitreous
Citicoline - Neurodegenerative Diseases
Not applicableCompletedIstituto di Ricerca Neuroftalmologia S.r.l.262018-03-212019-07-01
Role of Citicoline in Treatment of Newborns With Hypoxic Ischemic Encephalopathy
citicoline - Hypoxic-Ischemic Encephalopathy
Phase 3UnknownArmed Forces Hospital, Pakistan502017-06-152017-06-09
Citicoline in Non-Arteritic Ischemic Optic Neuropathy
Citicoline - Non-arteritic Ischemic Optic Neuropathy
Not applicableCompletedFondazione G.B. Bietti, IRCCS402017-02-202023-11-24
Ramelteon and Citicoline for Delirium
Ramelteon, Citicoline - Delirium
Phase 4WithdrawnUniversity of Texas Southwestern Medical Center2016-07-012017-11-09
Clinical Medication Development for Bipolar Disorder and Alcohol Use Disorders
Placebo, Citicoline, Pregnenolone - Alcohol Use Disorder, Bipolar Disorder
Phase 4CompletedSherwood Brown, MD, PhD962016-05-012024-10-09
Evaluation of the Effect of Citicoline and Docosahexaenoic Acid (DHA) on the Visual Function of Patients With Glaucoma
Citicoline, Docosahexaenoic Acid (DHA), Citicoline and Docosahexaenoic Acid (DHA) - Glaucoma
Not applicableCompletedInstitut Catala de Retina732015-03-122022-09-02
Citicoline for Alcohol Dependence
Placebo, Citicoline - Alcohol Dependence
Phase 4CompletedUniversity of Texas Southwestern Medical Center622014-04-012018-07-24
Effects of CDP-Choline on Gating and Cognitive Deficits in First Episode Schizophrenia
CDP-Choline, Cellulose - First Episode Schizophrenia
Phase 2UnknownUniversity of Ottawa402014-04-012014-03-17
Citicoline and Omega-3 Fatty Acid Effects in Veterans With Traumatic Brain Injury (TBI)
Citicoline, Omega-3, Rice bran oil - Traumatic Brain Injury, Substance Abuse
Not applicableWithdrawnDeborah Yurgelun-Todd2013-11-012015-01-19
Influence of Oral Treatment With Citicoline for the Prevention of Radiation Optic Neuropathy in Patients Treated for Uveal Melanomas With Proton Beam Therapy
CITICOLINE, PLACEBO - Uveal Melanoma
Not applicableCompletedCentre Hospitalier Universitaire de Nice212012-06-252025-02-24
Cognizin Citicoline Dosing in a Healthy Adolescent Male Population
Citicoline, Microcrystalline Cellulose - Neurocognitive Improvement
Early Phase 1CompletedDeborah Yurgelun-Todd842012-06-012019-02-18

Showing 20 of 31. Sign in to see all of them.

Conditions studied

Brain Injuries, Traumatic (4)  ·  Bipolar Disorder (3)  ·  Glaucoma (3)  ·  Alcoholism (2)  ·  Cocaine-Related Disorders (2)  ·  Delirium (2)  ·  Hypoxia-Ischemia, Brain (2)  ·  Ischemic Stroke (2)  ·  Stroke (2)  ·  Substance-Related Disorders (2)  ·  Amphetamine-Related Disorders (1)  ·  Asphyxia Neonatorum (1)  ·  Brain Injuries (1)  ·  COVID-19 (1)  ·  Cerebral Infarction (1)

Sponsors

University of Texas Southwestern Medical Center (5)  ·  Fondazione G.B. Bietti, IRCCS (3)  ·  Deborah Yurgelun-Todd (2)  ·  Mclean Hospital (2)  ·  Sherief Abd-Elsalam (2)  ·  Armed Forces Hospital, Pakistan (1)  ·  Centre Hospitalier Universitaire de Nice (1)  ·  Clinical Institute of the Brain, Russia (1)  ·  Dinara Zhumanbayeva (1)  ·  Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (1)  ·  Ferrer Internacional S.A. (1)  ·  Fondazione IRCCS Policlinico San Matteo di Pavia (1)  ·  Institut Catala de Retina (1)  ·  Istituto di Ricerca Neuroftalmologia S.r.l. (1)  ·  Khyber Girls Medical College (1)

Countries

United States (14)  ·  Italy (6)  ·  Egypt (2)  ·  Pakistan (2)  ·  Spain (2)  ·  Canada (1)  ·  France (1)  ·  Germany (1)  ·  Portugal (1)  ·  Russia (1)

Top investigators

Sherwood Brown, M.D., Ph.D. (2)  ·  Abeer Salamah, Lecturer (1)  ·  Abeer Salamah, MD (1)  ·  Alfonso Anton, MD, PhD (1)  ·  Beth Ansel, PhD (1)  ·  E. Sherwood Brown, MD, PhD (1)  ·  E. Sherwood Brown, PH.D., M.D. (1)  ·  Francesco Oddone, MD, PHD (1)  ·  Giuseppe Bellelli, Medical doctor, full professor (1)  ·  Howard Eisenberg, MD (1)  ·  Jack Jallo, MD, PhD (1)  ·  John Ward, MD (1)  ·  Joseph Ricker, PhD (1)  ·  May R Elsheikh, Lecturer (1)

Results publications

PMID 16249960, PMID 31348806, PMID 10366081, PMID 11006239, PMID 11165541, PMID 11235540, PMID 12640353, PMID 15555526, PMID 16406535, PMID 18557920, PMID 18929133, PMID 21397626, PMID 22691567, PMID 23168823, PMID 24881599, PMID 25998279, PMID 26004075, PMID 26891880, PMID 28676014, PMID 29570721, PMID 29879191, PMID 30291364, PMID 31872278, PMID 32079996, PMID 33804675, PMID 37173784, PMID 38760804, PMID 42765966, PMID 7905600

NIH funding

2025 (1), K23HD049626 (1), R01DA019238 (1), R01DA022460 (1), R01DA024007 (1)